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Abstract
Background: The purpose of this study was to estimate awareness and opinions about supervised smoking facilities
(SSFs) for smoking crack cocaine and other stimulants and make comparisons with awareness and opinions about
supervised injection facilities (SIFs) in Ontario, Canada.
Methods: We used data from a 2009 telephone survey of a representative adult sample. The survey asked
about awareness of, and level of support for, the implementation of SSFs and SIFs. Data were analysed using
statistical models for complex survey data, which account for stratified sampling and incorporate sampling weights.
Results: A total of 1035 participated in the survey. Significantly fewer had knowledge about SSFs (17.9 %) than about
SIFs (57.6 %). Fewer strongly agreed with implementation of SSFs (19.6 %) than SIFs (28.3 %). Just over half (51.1 %) of
participants somewhat agreed or disagreed, 15.7 % strongly agreed, and 10.6 % strongly disagreed with implementing
both SSFs and SIFs.
Conclusions: Members of the public in Ontario had little knowledge of SSFs compared to SIFs. Recent federal
government changes in Canada may provide the leadership environment necessary to ensure that innovative,
evidence-based harm reduction programs such as SSFs are developed and implemented.
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Background
The past thirty years have seen an expansion in public
health programming to prevent drug-related harms for
people who inject illicit drugs such as heroin, other opi-
oids, cocaine and crack cocaine, and crystal metham-
phetamine. Well-known examples include needle and
syringe programs and methadone maintenance treat-
ment, both of which are effective at reducing human im-
munodeficiency virus (HIV) transmission [1, 2]. In
recent years, there have been increasing calls to base
drug policy and programming on evidence instead of
ideology [3], including for example the implementation
of supervised consumption facilities. These programs
have been implemented in some countries to provide a
hygienic environment where clients can inject and/or
smoke illicitly obtained drugs [4].
Supervised injection facilities (SIFs) are a common
type of consumption facility and a programmatic
innovation with the goal of addressing injection-related
harms and risks, including: reducing transmission of
HIV, hepatitis C virus (HCV), and other blood-borne
infections; decreasing morbidity, overdose and mortality
associated with public drug use; minimising public dis-
turbances and drug-related litter; and increasing contact
between people who use drugs and health and social
services [5–7]. Across the world, there are an estimated
90 supervised consumption facilities implemented where
problem drug use continues despite the availability of
drug treatment, needle and syringe programs, social
services, and attempts by police to reduce drug-related
public disorder and drug markets [8, 9]. A large and
growing literature from Australia, Europe, and Canada
has demonstrated numerous benefits of SIFs [10–16].
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Across North America and Europe, smoking of stimu-
lants such as crack cocaine is prevalent and associated
with many negative health and social effects [17–21]. Re-
ports suggest that the sharing of smoking equipment is
common [22] and potentially exposes smokers to HCV
and tuberculosis [23–26]. However, public health re-
sponses to these harms have been slower to develop than
those related to injection drug use [22]. Nevertheless,
some Canadian public health departments distribute low-
cost or free safer crack cocaine smoking equipment (e.g.,
glass stems and mouthpieces) to reduce equipment shar-
ing and potential injuries to the hands and mouth from
using damaged smoking equipment [27]. In the United
Kingdom, where smoking of heroin is more prevalent,
some programs now distribute foil sheets designed to en-
courage the transition from injecting to heroin smoking
[28]. Similar to SIFs, supervised smoking facilities (SSFs)
operate in some European countries to reduce illicit drug
smoking-related harms such as disease transmission, mor-
bidity associated with public drug use, public disorder,
drug-related litter, and limited access to health and social
services [6].
There are no legally sanctioned SSFs in North America,
although there have been calls for implementation of these
programs [29, 30]. Results from an ethnographic study of
an unsanctioned SSF in Vancouver, Canada operated by a
drug user-led organisation showed the potential of SSFs to
attract highly vulnerable people who smoke crack cocaine
and to minimise client exposure to interpersonal violence
[31]. However, the study showed only modest potential to
reduce crack pipe sharing [31]. In other cities in Canada
where crack cocaine smoking is prevalent, over two-thirds
of people who smoke crack cocaine reported a willingness
to use a SSF [5, 30].
Interest in these facilities has been raised by both pub-
lic health officials and advocates in Canadian cities
where crack cocaine smoking is prevalent [5, 32]. To our
knowledge, there are no published studies that report
public perception of SSFs or reports comparing opinions
about SSFs relative to SIFs. However, public opinion is a
factor in decision making regarding implementation of
public health programs [33, 34]. The goal of our study
was to estimate the level of public awareness of SSFs in
general and relative to SIFs. In addition, we estimated
the level of public agreement or lack thereof regarding
implementation of SSFs, both in general and with re-
spect to specific SSF goals.
Methods
Study design and data source
We analysed data from the Centre for Addiction and
Mental Health (CAMH) Monitor survey, an annual cross-
sectional survey that used computer-assisted telephone in-
terviews to ask participants from Ontario, Canada about
drug issues and policies as well as substance use and men-
tal health. We used the 2009 survey, in which about 2000
adults were selected. Sampling followed a two-stage prob-
ability design. First, households were sampled using ran-
domly selected telephone numbers within six regional
strata. Second, the person within each household who was
both age 18 or over and had the most recent birthday was
selected. Fluency in English or French was required for
eligibility. All participants provided informed consent.
Additional information is available in the CAMH Monitor
technical guide [35]. This study was approved by the
Research Ethics Board at the Centre for Addiction and
Mental Health.
For six of the months in 2009, survey participants were
first asked about their opinions regarding SIFs and next
asked about their opinions related to SSFs [36]. Prior to
being asked for their opinions, participants were told that
they would be asked questions about SIFs and were pro-
vided with the following description: “The Vancouver
supervised injection facility, ‘Insite’, provides a place super-
vised by health care workers for drug users to inject their
drugs. Several other cities in Canada are considering start-
ing up similar programs.” Participants were asked if they
strongly agreed, somewhat agreed, somewhat disagreed or
strongly disagreed with each of the following statements:
1. Supervised injection facilities should be made
available to injection drug users, to encourage safer
drug injection.
2. Supervised injection facilities should be made
available if it can be shown that they reduce
overdose deaths or infectious disease among users.
3. Supervised injection facilities should be made
available if they can increase drug users’ contact
with health and social workers.
4. Supervised injection facilities should be made available
if it can be shown that they reduce neighbourhood
problems related to injection drug use.
After asking about SIFs, interviewers informed partici-
pants that, “Several cities in Canada are considering
starting up similar facilities supervised by health care
workers for drug users to smoke drugs like crack co-
caine and methamphetamine. The next few questions
are about your views on these facilities.” Specifically,
participants were asked:
1. Have you ever read, seen or heard any information
about supervised smoking facilities?
2. Please indicate if you strongly agree, somewhat
agree, somewhat disagree or strongly disagree with
the following statements:
a. Supervised smoking facilities should be made
available to people who smoke drugs like crack
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cocaine and methamphetamine to encourage
safer drug consumption
b. Supervised smoking facilities should be made
available if it can be shown that they reduce
infectious disease among to people who smoke
drugs like crack cocaine and methamphetamine
c. Supervised smoking facilities should be made
available if they can increase drug users’ contact
with health and social workers
d. Supervised smoking facilities should be made
available if it can be shown that they reduce
neighbourhood problems related to consumption
of drugs like crack cocaine and methamphetamine.
In contrast to Firestone-Cruz and colleagues [37], we
created a composite measure of public opinion to high-
light those with mixed opinions about SIFs. Focus group
data from residents, business owners, and community
service providers in our study also revealed high levels
of ambivalence about SIF implementation [38]. We clas-
sified responses for each of the latter four questions into
three categories: strongly disagree; somewhat agree or
disagree (participants who might change their views);
and strongly agree. Finally, we grouped responses to the
four goals into a single composite variable using the
following categories:
 Strongly agreed: participants who strongly agreed
with all four goals for SSFs and SIFs
 Strongly disagreed: participants who strongly
disagreed with all four goals for SSFs and SIFs
 Mixed opinions: all other patterns of responses
Analysis
We used statistical models for complex survey data,
which account for stratified sampling and incorporate
sampling weights. These weights reflect study design
and population characteristics such that the final survey
results are representative of the Ontario population aged
18 years in the survey year. Sampling weights also pro-
vide accurate confidence intervals. A full description of
the analytic methods can be found in a previously
published study [36]. We compared the sample who
answered questions to the entire population sample and
to data from the 2006 Ontario Census. We performed
chi-square tests of independence, taking into account
the complex survey design, to determine the association
between SSF awareness and each of the four specific SSF
goals. We used a two-tailed p-value threshold of 0.05 to
assess statistical significance and did not adjust for mul-
tiple comparisons.
We analysed independent predictors of knowledge of
SSF using logistic regression and of support for SSF
goals using multinomial logistic regression, with a 3-
level dependent variable based on the composite support
variable. Both methods used weights for complex survey
designs. We used a non-parsimonious approach for each
method and included all potential covariates listed in
Table 1. Multinomial regression results are reported
compared to the “mixed opinions” group as both the
relative risk of strongly agreeing and of strongly dis-
agreeing with the goals of SSFs.
All analyses were completed using SAS 9.3 (SAS
Institute), R 3.0.2 (R Core Team), and Stata version
13.1 (StataCorp).
Results
In 2009, 1035 participants were asked questions about
SIFs and SSFs. After applying survey weights, the typical
respondent was female (55.0 %), aged 35 and over
(72.2 %), employed full-time (62.4 %), and had com-
pleted at least some post-secondary education (68.1 %;
Table 1). The participants who answered questions about
SIFs and SSFs had a similar employment and income
distribution as the Canadian population but women,
older people, people who were married, and well-
educated people were somewhat over-represented. At
least one question regarding opinions about SIF or SSF
implementation was not answered by 182 and 198 par-
ticipants, respectively.
Using complex survey designs to estimate proportions,
significantly fewer participants had ever read, seen or
heard any information about SSFs (17.9 %, 95 % CI
15.1 % to 21.1 %) than SIFs (57.6 %, 95 % CI 53.9 % to
61.2 %); the difference was 39.7 % (95 % CI 35.8 % to
43.6 %; p < 0.001; difference estimated using the delta
method using a t-distribution with 1010 degrees of free-
dom). Among those with no prior knowledge of SSFs,
48.8 % also had no prior knowledge of SIFs and among
those with no prior knowledge of SIFs, 95.4 % also had
no prior knowledge of SIFs thus 40.1 % of the popula-
tion had no prior knowledge of either type of facility and
15.9 % had prior knowledge of both types (data not
shown). Independent predictors of knowledge of SSFs
included older age, male sex, having a university degree,
and being a health care worker; people who immigrated
to Canada were less likely have prior knowledge of SSFs
(Table 2).
Participants had varied opinions about implementation
of SSFs and SIFs. When asked if SSFs should be made
available to people who smoke drugs such as crack co-
caine and crystal methamphetamine, 64.2 % of Ontarians
held a mixed overall opinion, 19.6 % strongly agreed,
and 16.1 % strongly disagreed (Table 3). The distribution
of responses was significantly different when participants
were asked about SIFs; 28.3 % of participants strongly
agreed and 11.6 % strongly disagreed. Analyses by each
program goal showed significantly fewer participants
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strongly agreed with implementation of SSFs than with
implementation of SIFs (Table 3). For example, 20.5 %
strongly agreed with implementation of SSFs to
encourage safer drug use compared to 30.6 % who
strongly agreed with implementation of SIFs for that
purpose. For each goal, significantly more participants
Table 1 Demographic characteristicsa




Female 55.0 % 51.5 % 51.9 % 1035; 1029 0.049; 1
Age (years)
18 to 34 25.5 % 26.3 % 28.5 % 999; 993 0.012; 2
35 to 54 39.2 % 41.7 % 40.4 %
55 and older 35.3 % 32.0 % 31.1 %
Employment status
Employed 63.2 % 63.7 % 64.5 % 1020; 1014 0.654; 2
Unemployed 4.5 % 5.1 % 4.1 %
Other (student, retired, homemaker, disability, etc.) 32.3 % 31.1 % 31.4 %
Household income in the past year before taxes
Less than $30,000 13.0 % 11.4 % 12.6 % 730; 724 0.952; 3
Between $30,000 and $49,999,99 16.1 % 15.6 % 16.6 %
Between $50,000 and $79,999,99 24.1 % 26.0 % 24.6 %
More than $80,000 46.8 % 47.0 % 46.1 %
Highest level of education attained
Less than high school 10.5 % 10.6 % 18.6 % 1018; 1012 <0.001; 3
Completed high school 20.4 % 21.2 % 27.8 %
Some post-secondary (college or university) 34.3 % 35.6 % 32.1 %
University degree 34.8 % 32.7 % 21.4 %
Marital Status
Married/living with partner 71.0 % 69.1 % 62.9 % 1014; 1018 <0.001; 2
Previously married (divorced, widowed, separated) 10.6 % 10.6 % 14.1 %
Never married 18.4 % 20.3 % 23.1 %
Smoking Status NA 1028; 1022
Current 17.9 % 18.6 %
Former 25.7 % 26.5 %
Never 56.4 % 54.9 %
Religious Service Attendance, past 12 months NA 969; 963
None 35.8 % 38.1 %
1 t0 6 times 29.3 % 27.7 %
7 or more times 34.9 % 34.2 %
Alcohol use in the past 12 months 79.0 % 79.1 % NA 1031; 1025
Cannabis use in the past 12 months 11.8 % 13.2 % NA 1033; 1027
Fair or Poor Self-reported Health 9.6 % 10.5 % NA 1029; 1023
Fair or Poor Self-reported Mental Health 6.2 % 5.7 % NA 1025; 1019
Health care worker 6.8 % 6.1 % NA 908; 902
Immigrant to Canada 27.2 % 27.5 % NA 1014; 1008
Urban residence 80.3 % 82.9 % NA 1035; 1029
aProportions estimated from one-way tables using complex survey designs. Total survey sample size = 2037. Census estimates are from the 2006 Canadian Census
individual microuse data (http://www5.statcan.gc.ca/olc-cel/olc.action?ObjId=95M0028X&ObjType=2) for Ontario population aged 18 and older using individual
weighting factors. P-values compare values in the current sample to population estimates using Pearson’s chi-square test. NA denotes not available
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strongly disagreed with implementation of SSFs than
strongly disagreed with implementation of SIFs.
Bivariate analyses showed that just over half of Ontarians
(51.1 %) somewhat agreed/disagreed, 15.7 % strongly agreed
and 10.6 % strongly disagreed with implementing both SSFs
and SIFs (Table 4).
Prior knowledge of SSFs influenced support for imple-
mentation. Participants who had prior knowledge of SSFs
were more likely to strongly agree with implementation of
SSFs on the composite measure of agreement than those
who did not have prior knowledge (28.4 % vs. 16.8 %; differ-
ence 11.6 % [95 % CI 2.7 % to 20.5 %]) and less likely to re-
port mixed opinions (55.1 % vs. 66.7 %; difference -11.6 %
[95 % CI -22.1 % to -1.1 %]; Table 5). Participants with prior
knowledge of SSFs were also more supportive of SSF
implementation in relation to the goals of encouraging
safer drug use (difference 12.8 % reducing infectious
diseases (difference 14.9 % and slightly more likely to
Table 2 Multvariable analysis of knowledge of supervised smoking facilities
Variable Odds ratio (95 % Confidence Interval)
Age (per decade) 1.17 (1.02 to 1.34)
Male sex 1.88 (1.22 to 2.92)
Household income in the past year before taxes
Less than $30,000 1.00 (Referent)
Between $30,000 and $49,999,99 0.63 (0.31 to 1.29)
Between $50,000 and $79,999,99 0.57 (0.28 to 1.16)
More than $80,000 0.91 (0.44 to 1.89)
Highest level of education attained
Less than high school 1.00 (Referent)
Completed high school 0.75 (0.36 to 1.56)
Some post-secondary (college or 1.74 (0.85 to 3.58)
University degree 2.59 (1.16 to 5.78)
Marital Status
Married/Living with partner 1.00 (Referent)
Previously married 0.84 (0.45 to 1.56)
Never married 1.33 (0.71 to 2.46)
Smoking Status
Current 1.00 (Referent)
Former 1.04 (0.51 to 2.09)
Never 0.55 (0.31 to 0.99)
Religious Service Attendance, past 12 months
None 1.00 (Referent)
1 to 6 times 0.62 (0.36 to 1.06)
7 or more times 0.88 (0.52 to 1.49)
Employment status
Employed 1.00 (Referent)
Unemployed 1.31 (0.45 to 3.80)
Other (student, retired, homemaker) 1.18 (0.68 to 2.05)
Alcohol use in the past 12 months 0.84 (0.50 to 1.40)
Cannabis use in the past 12 months 1.25 (0.57 to 2.73)
Fair or Poor Self-reported Health 1.24 (0.62 to 2.51)
Fair or Poor Self-reported Mental Health 0.44 (0.17 to 1.10)
Health care worker 2.55 (1.08 to 6.01)
Immigrant to Canada 0.47 (0.28 to 0.81)
Urban residence 0.89 (0.56 to 1.44)
Odds ratios estimated using logistic regression for complex survey designs. Statistical significance assessed using t-distribution with 610 degrees of freedom
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support implementation for increasing contact with
health and social workers (difference 11.1 %), but not
significantly associated with agreement to implement
SSFs to reduce neighbourhood problems (difference
6.7 % Strong disagreement with implementation of SSFs
overall was not influenced by prior awareness of SSFs
except for the goal of encouraging safer drug use, where
participants who were not aware of SSFs were more
likely to strongly disagree with implementation (41.4 %
vs. 29.6 %).
Few variables were predictive of either strongly agree-
ing or strongly disagreeing with the goals of SSFs
(Table 6). People with an annual income between
$50,000 and $80,000 and those who attended religious
services 7 or more times in the year prior to being sur-
veyed were significantly less likely to agree with the goals
of SSFs compared to those who somewhat agreed/dis-
agreed, whereas people who smoked cannabis in the past
12 months were significantly less likely to disagree with
the goals of SSFs compared to those who somewhat
agreed/disagreed. Post-estimation adjustment predicted
for strongly disagreeing with the goals of SIFs for people
with no, 1 to 6, and 7 or more religious service atten-
dances per year were 9.3 %, 9.5 %, and 13.1 %.
Table 3 Difference in opinions about SSFs and SIFS by composite measure and specific goals
Supervised smoking Supervised injection Difference p-value Design
Degrees of
Freedom
Goal of facilitya Weighted percent
(95 % Confidence Interval)
Weighted percent
(95 % Confidence Interval)
Weighted percent
(95 % Confidence Interval)
Composite measure
Strongly agree 19.6 % (16.5 % to 23.2 %) 28.3 % (24.6 % to 32.3 %) -8.7 % (-12.2 % to -5.2 %) <0.001 772
Somewhat agree/disagree 64.2 % (60.1 % to 68.2 %) 60.1 % (55.9 % to 64.2 %) 4.1 % (0.1 % to 8.1 %) 0.046
Strongly disagree 16.1 % (13.3 % to 19.4 %) 11.6 % (9.1 % to 14.6 %) 4.6 % (2.6 % to 6.5 %) <0.001
Supervised smoking facilities should be made available to people who smoke drugs like crack cocaine and methamphetamine to encourage safer
drug use
Strongly agree 20.5 % (17.3 % to 24.%) 30.6 % (27.% to 34.5 %) -10.1 % (-13.7 % to -6.6 %) <0.001 838
Somewhat agree/disagree 40.5 % (36.5 % to 44.6 %) 40.3 % (36.3 % to 44.4 %) 0.2 % (-4.0 % to 4.3 %) 0.932
Strongly disagree 39.1 % (35.2 % to 43.1 %) 29.1 % (25.6 % to 32.9 %) 10.% (6.9 % to 13.%) <0.001
Supervised smoking facilities should be made available if it can be shown that they reduce infectious disease among people who smoke drugs like
crack cocaine and methamphetamine
Strongly agree 35.2 % (31.4 % to 39.2 %) 49.4 % (45.4 % to 53.4 %) -14.2 % (-17.7 % to -10.7 %) <0.001 881
Somewhat agree/disagree 39.9 % (36.0 % to 43.9 %) 32.4 % (28.9 % to 36.2 %) 7.4 % (3.5 % to 11.4 %) <0.001
Strongly disagree 24.9 % (21.7 % to 28.4 %) 18.1 % (15.3 % to 21.4 %) 6.8 % (4.3 % to 9.3 %) <0.001
Supervised smoking facilities should be made available if they can increase drug users’ contact with health and social workers
Strongly agree 40.1 % (36.3 % to 44.1 %) 48.3 % (44.4 % to 52.3 %) -8.2 % (-11.3 % to -5.%) <0.001 886
Somewhat agree/disagree 40.% (36.2 % to 44.%) 37.2 % (33.4 % to 41.1 %) 2.9 % (-0.5 % to 6.3 %) 0.097
Strongly disagree 19.8 % (16.9 % to 23.1 %) 14.5 % (11.9 % to 17.5 %) 5.3 % (3.1 % to 7.5 %) <0.001
Supervised smoking facilities should be made available if it can be shown that they reduce neighbourhood problems related to use of drugs like
crack cocaine and methamphetamine
Strongly agree 45.7 % (41.8 % to 49.7 %) 56.1 % (52.2 % to 60.%) -10.4 % (-13.4 % to -7.4 %) <0.001 910
Somewhat agree/disagree 36.6 % (32.9 % to 40.4 %) 31.% (27.5 % to 34.8 %) 5.6 % (2.4 % to 8.7 %) <0.001
Strongly disagree 17.7 % (15.% to 20.8 %) 12.9 % (10.5 % to 15.7 %) 4.8 % (3.1 % to 6.6 %) <0.001
aSupervised injection questions were worded correspondingly to ask about drug injection. Proportions estimated using complex survey designs. Differences
calculated using t-distribution for differences with specified degrees of freedom. For our survey design, sample size = design degrees of freedom + number of
strata (6)
Table 4 Bivariate analysis of composite measures of agreement regarding supervised injection and smoking facilitiesa
Supervised smoking composite measure
Supervised injection composite measure Strongly agree Somewhat agree/disagree Strongly disagree p-value
Strongly Agree 15.7 % 12.1 % 0.5 %
Somewhat agree/disagree 3.9 % 51.1 % 5.1 %
Strongly disagree 0.0 % 1.0 % 10.6 % <0.001
aProportions estimated using complex survey designs. Test statistic for distribution uses Pearson’s chi-square test converted to an F-statistic for the survey design
with the second-order correction of Rao and Scott with F(3.90, 3011.27) = 123.7119 [46]
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Discussion
Although there are reports of decline in crack cocaine
use in both Canada and the United States [39, 40], its
use remains a public health concern. However, as noted
above, public health programming for people who
smoke crack cocaine lags behind what is available for
people who inject drugs despite evidence of serious, and
sometimes fatal, harms associated with smoking these
drugs [41, 42]. To our knowledge, this is the first study
to report public opinion about SSFs.
Lack of innovative public health responses to reduce
stimulant drug-related problems parallels the lack of aware-
ness about SSFs in the public opinion data. Our results
show that less than 20 % of Ontarians were aware of SSF
models whereas almost 60 % were aware of SIF models.
SSF awareness was associated with older age, higher educa-
tion and male sex. These results suggest the need for edu-
cation among broad societal groups regarding supervised
smoking. Compared to smoking facilities, we generally
found stronger support for and fewer negative sentiments
Table 5 Agreement with goals of a supervised smoking facility by level of awarenessa
Aware of supervised smoking facilities






Strongly agree 16.8 %
(13.6 % to 20.6 %)
28.4 %
(21.0 % to 37.3 %)
11.6 %
(2.7 % to 20.5 %)
0.011 Difference: 829 Distribution:
F(1.99, 1652.12) = 4.0000
Somewhat agree/disagree 66.7 %
(62.3 % to 70.8 %)
55.1 %
(45.4 % to 64.4 %)
-11.6 %
(-22.1 % to -1.1 %)
0.030
Strongly disagree 16.5 %
(13.5 % to 20.0 %)
16.5 %
(10.5 % to 25.0 %)
0.0 %
(-7.9 % to 7.9 %)
0.995 0.019
Supervised smoking facilities should be made available to people who smoke drugs like crack cocaine and methamphetamine to encourage safer
drug use
Strongly agree 17.3 %
(14.2 % to 21.0 %)
30.2 %
(22.7 % to 38.9 %)
12.8 %
(4.0 % to 21.6 %)
0.005 Difference: 889 Distribution:
F(1.97, 1752.21) = 5.3906
Somewhat agree/disagree 41.2 %
(37.0 % to 45.6 %)
40.3 %
(31.0 % to 50.3 %)
-0.9 %
(-11.6 % to 9.8 %)
0.863
Strongly disagree 41.4 %
(37.2 % to 45.7 %)
29.6 %
(22.0 % to 38.5 %)
-11.9 %
(-21.2 % to -2.5 %)
0.013 0.005
Supervised smoking facilities should be made available if it can be shown that they reduce infectious disease among people who smoke drugs like
crack cocaine and methamphetamine
Strongly agree 31.8 %
(27.8 % to 36.0 %)
46.7 %
(37.4 % to 56.3 %)
14.9 %
(4.5 % to 25.3 %)
0.005 Difference: 910 Distribution:
F(1.98, 1802.95) = 4.4720
Somewhat agree/disagree 42.3 %
(38.1 % to 46.6 %)
30.5 %
(22.0 % to 40.5 %)
-11.8 %
(-22.1 % to -1.6 %)
0.023
Strongly disagree 25.9 %
(22.4 % to 29.7 %)
22.8 %
(16.0 % to 31.4 %)
-3.1 %
(-11.6 % to 5.4 %)
0.478 0.012
Supervised smoking facilities should be made available if they can increase drug users’ contact with health and social workers
Strongly agree 37.7 %
(33.6 % to 42.0 %)
48.8 %
(39.3 % to 58.4 %)
11.1 %
(0.6 % to 21.6 %)
0.039 Difference: 919 Distribution:
F(1.98, 1823.00) = 2.2802
Somewhat agree/disagree 42.1 %
(37.9 % to 46.3 %)
33.1 %
(24.3 % to 43.3 %)
-9.0 %
(-19.5 % to 1.5 %)
0.093
Strongly disagree 20.2 %
(17.1 % to 23.8 %)
18.1 %
(12.0 % to 26.4 %)
-2.1 %
(-10.0 % to 5.8 %)
0.599 0.103
Supervised smoking facilities should be made available if it can be shown that they reduce neighbourhood problems related to use of drugs like
crack cocaine and methamphetamine
Strongly agree 44.0 %
(39.8 % to 48.2 %)
50.7 %
(41.1 % to 60.2 %)
6.7 %
(-3.8 % to 17.2 %)
0.213 Difference: 934 Distribution:
F(1.97, 1844.31) = 1.1145
Somewhat agree/disagree 38.3 %
(34.3 % to 42.4 %)
30.7 %
(22.0 % to 40.9 %)
-7.6 %
(-18.0 % to 2.8 %)
0.151
Strongly disagree 17.8 %
(14.9 % to 21.1 %)
18.7 %
(12.5 % to 26.9 %)
0.9 %
(-6.9 % to 8.8 %)
0.821 0.328
aCI denotes confidence interval. Proportions estimated using complex survey designs. Differences calculated using t-distribution for differences with specified
degrees of freedom. Test statistic for distribution uses Pearson’s chi-square test converted to an F-statistic for the survey design with the second-order correction
of Rao and Scott with specified degrees of freedom [46]
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about injection facilities. Support for SSFs was strongest
when the goals of a facility were presented as reducing
neighbourhood problems related to drug use, increasing
contact between people who use drugs and health and so-
cial workers, and reducing infectious diseases. Even for
these goals, however, we observed about 8 to 14 % higher
support for injection facilities, rather than smoking fa-
cilities. We found few consistent predictors of oppos-
ition to SSF goals although regular attendance at
religious services was significant. These findings might
indicate that both individual values and scepticism
about the effectiveness of SSFs, reflecting the weaker
Table 6 Multivariable analysis of agreement with the goals of supervised smoking facilities
Relative risk ratio (95 % Confidence Interval)
Variable Strongly agree vs. somewhat agree/disagree Strongly disagree vs. somewhat agree/disagree
Age (per decade) 1.09 (0.93 to 1.27) 0.93 (0.71 to 1.23)
Male sex 1.18 (0.71 to 1.99) 1.36 (0.64 to 2.89)
Household income in the past year before taxes
Less than $30,000 1.00 (Referent) 1.00 (Referent)
Between $30,000 and $49,999,99 0.73 (0.34 to 1.58) 0.91 (0.29 to 2.86)
Between $50,000 and $79,999,99 0.35 (0.15 to 0.81) 0.51 (0.17 to 1.52)
More than $80,000 0.85 (0.38 to 1.93) 1.32 (0.36 to 4.82)
Highest level of education attained
Less than high school 1.00 (Referent) 1.00 (Referent)
Completed high school 1.14 (0.46 to 2.82) 0.64 (0.24 to 1.71)
Some post-secondary (college or 0.74 (0.31 to 1.81) 0.46 (0.18 to 1.22)
University degree 1.52 (0.58 to 3.98) 0.43 (0.13 to 1.40)
Marital Status
Married/Living with partner 1.00 (Referent) 1.00 (Referent)
Previously married 0.80 (0.37 to 1.72) 1.10 (0.43 to 2.80)
Never married 1.86 (0.91 to 3.77) 1.61 (0.57 to 4.55)
Smoking Status
Current 1.00 (Referent) 1.00 (Referent)
Former 0.79 (0.37 to 1.67) 1.04 (0.36 to 2.99)
Never 0.90 (0.48 to 1.71) 0.78 (0.31 to 1.99)
Religious Service Attendance, past 12 months
None 1.00 (Referent) 1.00 (Referent)
1 to 6 times 0.61 (0.34 to 1.08) 0.85 (0.30 to 2.36)
7 or more times 0.24 (0.13 to 0.45) 0.89 (0.37 to 2.16)
Employment status
Employed 1.00 (Referent) 1.00 (Referent)
Unemployed 0.86 (0.28 to 2.67) 0.86 (0.14 to 5.06)
Other (student, retired, homemaker) 0.97 (0.53 to 1.76) 0.69 (0.26 to 1.81)
Alcohol use in the past 12 months 0.71 (0.36 to 1.37) 0.78 (0.35 to 1.75)
Cannabis use in the past 12 months 0.81 (0.38 to 1.72) 0.16 (0.03 to 0.76)
Fair or Poor Self-reported Health 0.96 (0.39 to 2.37) 1.03 (0.30 to 3.50)
Fair or Poor Self-reported Mental Health 0.68 (0.26 to 1.77) 0.66 (0.12 to 3.67)
Health care worker 1.37 (0.59 to 3.17) 0.21 (0.02 to 1.79)
Immigrant to Canada 0.83 (0.44 to 1.55) 1.49 (0.63 to 3.57)
Urban residence 1.12 (0.62 to 2.02) 0.71 (0.34 to 1.51)
Relative risk ratios estimated using multinomial logistic regression for complex survey designs. Statistical significance assessed using t-distribution with 536 degrees
of freedom
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evidence base for SSFs compared to SIFs, underlie op-
position. Our results underscore the need for ongoing
research, including demonstration projects.
The survey was prone to sampling biases, as people who
do not speak English or French and residents without a
landline were excluded from participating. Nevertheless,
the response rate was reasonable (57 %) for a telephone
survey [35, 43] and the sampling was systematic. Thus,
these data are population-based – unlike other studies
assessing public opinion about SIFs that use convenience
samples – and therefore more likely to be representative
of true opinion, although highly educated people were
somewhat over-represented, as commonly found in tele-
phone surveys. The survey represents the last available data
(in 2009), but SIFs have remained a prominent policy discus-
sion topic since then. While our results might underestimate
awareness of SIFs, they likely are still reflective of awareness
of SSFs, which have been proposed but not implemented in
Canada and are discussed much less frequently.
Grund and colleagues [22] note that stimulant use presents
unique challenges requiring innovative and multidisciplinary
responses and that people who use stimulants ‘must enjoy
the fundamental human right to health protection, as stipu-
lated by Article 25 of the Universal Declaration of Human
Rights’ (p. 212). SSFs represent an innovation in program-
ming that have been implemented in some European cities
[9]. Until recently, harm reduction advocates in Canada have
despaired over introducing innovations such as these given
the opposition of the former Conservative federal govern-
ment to harm reduction [44]. Again, our data also show low
levels of public support for SSFs. Importantly, public opinion
is identified in recent legislation, Bill C-2, passed in Canada
that identified stakeholder opinion as one of the inputs that
would be considered in any application for new SIFs [http://
www.huffingtonpost.ca/2015/06/22/critics-up-in-arms-over-
f_n_7640154.html]. However, public health advocates are
hopeful that another SIF recently approved by the new fed-
eral government signals improved chances for approval
of other applications for SIFs. [http://www.theglobeandmail.
com/news/british-columbia/vancouver-facility-becomes-
canadas-second-approved-supervised-injection-site/
article28216557/]. The newly elected Prime Minister Justin
Trudeau is on record expressing support for SIFs [http://
www.straight.com/blogra/404631/justin-trudeau-tells-ubc-
students-he-wants-supervised-injection-sites-across-canada],
reflecting the leadership identified as necessary for
innovation in programming and policy [45].
Conclusions
The lack of public knowledge or support of SSFs and
their potential positive impact on public health issues
associated with drug smoking presents barriers to ser-
vice providers and community advocates who are con-
templating implementation of SSFs in their jurisdiction.
Recent federal government changes in Canada may pro-
vide the leadership environment necessary to ensure that
innovative harm reduction programs such as SSFs are
developed based on evidence and implemented.
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